{"database": "openregs", "table": "docket_stats", "rows": [[66755, "FDA-2015-N-0030", "FDA", "Compounding of Human Drug Products Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket", "Rulemaking", 197422, 14, "2015-06-17T04:00:00Z", "2026-08-28T04:00:00Z", "2015-03-09T05:00:00Z", "2026-10-05T04:00:00Z"]], "columns": ["rowid", "id", "agency_id", "title", "docket_type", "comment_count", "document_count", "earliest_comment", "latest_comment", "earliest_document", "latest_document"], "primary_keys": ["rowid"], "primary_key_values": ["66755"], "units": {}, "query_ms": 4.117187985684723, "source": "U.S. government sources, plus a few identifier registries; each is listed on the methodology page", "source_url": "https://datadawn.org/methodology#data", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}